Drug
fosdenopterin hydrobromide
Marketed as NULIBRY.
Generic name
fosdenopterin hydrobromide
Brand names
NULIBRY
First FDA approval
2021-02-26
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| NDA214018 | NULIBRY | 2021-02-26 | SENTYNL THERAPS INC |
Manufacturers
SENTYNL THERAPS INC
Frequently asked questions
When was fosdenopterin hydrobromide FDA approved?
Earliest FDA approval on record: 2021-02-26.
What brand names are sold as fosdenopterin hydrobromide?
NULIBRY.
Sources
Appeal a fosdenopterin hydrobromide denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com